CS logo
small CS logo
Melanoma Institute Australia

Wollstonecraft, New South Wales, Australia
Educational institution in Wollstonecraft, New South Wales
The Poche Centre, 40 Rocklands Rd, Wollstonecraft NSW 2065

About Melanoma Institute Australia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Melanoma Institute Australia


During the past decade, Melanoma Institute Australia conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
2001-05-01
2009-09-01
Completed
120
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
1998-01-01
2012-04-01
Completed
169
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas
2004-04-01
2017-05-31
Completed
3,417
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis
2001-09-01
2011-12-01
Completed
73
Home Therapy With Replagal in Fabry Disease
2011-03-15
2017-09-30
Completed
127
Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)
2018-06-18
2024-11-01
Recruiting
120

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Melanoma Institute Australia" #1 sponsor was "Melanoma Institute Australia" with 5 trials, followed by "QBiotics Group Limited" with 2 trials sponsored, "Evaxion Biotech A/S" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Kinnate Biopharma" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Melanoma Institute Australia" #1 collaborator was "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Monash University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Melanoma Institute Australia


According to Clinical.Site data, the most researched conditions in "Melanoma Institute Australia" are "Melanoma" (8 trials), "Advanced Malignancies" (1 trials), "Anxiety and Fear" (1 trials), "Melanoma Stage III" (1 trials) and "Melanoma Stage IV" (1 trials). Many other conditions were trialed in "Melanoma Institute Australia" in a lesser frequency.

Clinical Trials Intervention Types at Melanoma Institute Australia


Most popular intervention types in "Melanoma Institute Australia" are "Drug" (12 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (2 trials), "tigilanol tiglate" (2 trials), "2D or 3D Melanoma Surveillance Photography" (1 trials), "Avelumab" (1 trials) and "Axitinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Melanoma Institute Australia


The vast majority of trials in "Melanoma Institute Australia" are 13 trials for "All" genders.

Clinical Trials Status at Melanoma Institute Australia


Currently, there are NaN active trials in "Melanoma Institute Australia". 2 are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Melanoma Institute Australia, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Melanoma Institute Australia, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status